Angiopoietin-like 3 (ANGPTL3) is another intriguing hyperlipidemia target, as evidenced by research showing that loss-of-function variations are linked to significantly lower LDL-cholesterol and triglyceride levels and a decreased risk of CHD [206]. The gene discussed is ANGPTL3; the disease is hyperlipidemia.